Petmed Express (NASDAQ:PETS) Upgraded at BidaskClub

BidaskClub upgraded shares of Petmed Express (NASDAQ:PETS) from a strong sell rating to a sell rating in a report issued on Wednesday morning, BidAskClub reports.

PETS opened at $16.23 on Wednesday. The firm’s fifty day moving average price is $16.42. The stock has a market cap of $329.24 million, a price-to-earnings ratio of 8.85 and a beta of 0.52. Petmed Express has a one year low of $15.00 and a one year high of $41.45.

Petmed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, May 6th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.14). Petmed Express had a return on equity of 28.96% and a net margin of 13.32%. The company had revenue of $64.57 million for the quarter, compared to the consensus estimate of $69.06 million. During the same period in the prior year, the firm posted $0.50 earnings per share. The business’s revenue was down 4.1% on a year-over-year basis.



Hedge funds and other institutional investors have recently bought and sold shares of the company. North Star Investment Management Corp. grew its stake in Petmed Express by 15.0% during the second quarter. North Star Investment Management Corp. now owns 153,743 shares of the company’s stock valued at $2,409,000 after acquiring an additional 20,004 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Petmed Express by 3,275.9% in the 2nd quarter. Nisa Investment Advisors LLC now owns 39,160 shares of the company’s stock worth $614,000 after buying an additional 38,000 shares in the last quarter. Ridgewood Investments LLC grew its stake in shares of Petmed Express by 48.6% in the 2nd quarter. Ridgewood Investments LLC now owns 33,106 shares of the company’s stock worth $519,000 after buying an additional 10,825 shares in the last quarter. Rothschild Investment Corp IL grew its stake in shares of Petmed Express by 55.7% in the 2nd quarter. Rothschild Investment Corp IL now owns 182,328 shares of the company’s stock worth $2,857,000 after buying an additional 65,208 shares in the last quarter. Finally, Scout Investments Inc. grew its stake in shares of Petmed Express by 63.9% in the 2nd quarter. Scout Investments Inc. now owns 132,699 shares of the company’s stock worth $2,079,000 after buying an additional 51,720 shares in the last quarter. 99.75% of the stock is owned by institutional investors.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Article: What are catch-up contributions?

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.